Society for Neuroscience 2024
Come visit us in Booth 424!
October 5 – 9 | McCormick Place Convention Center | Chicago, IL, USA
Meet us in Chicago for the annual Society for Neuroscience conference, where we’ll be showcasing our spatial biology solutions for life science imaging and analysis. Our solutions help scientists make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life.
Connect with our experts on the expo floor, at (our) vendor theater, or at (the Bruker) annual symposium to hear case studies, learn about our technology, and ask your questions. Our team is excited to help you discover how our spatial technology solutions can help you see the biology of life more clearly! See you there!
Bruker’s Satellite Event on Saturday, Oct 5th
Multimodal Neuronal-imaging: From Synapses to Circuits
Satisfy your sweet tooth while expanding your mind at Bruker’s 6th annual symposium on multimodal fluorescence imaging for neuroscience. Hear from leaders in the field who are using cutting‑edge techniques, including spatial biology, one‑photon, two‑photon, super-resolution, and light‑sheet—all while enjoying dessert on us. Don’t miss this exciting opportunity to dive into groundbreaking discoveries and advancements in neuroimaging!
This event is open to all SfN 2024 registrants.
Product Theater:
Highest Plex Spatial Multiomics as a Discovery Tool for Cellular Aging and Pathogenesis in Alzheimer’s Disease
Speaker: Miranda E. Orr, Ph.D, Alyssa Rosenbloom, PhD
Date & Time: Monday, October 7, 4–4:30 p.m.
Location: MCP Exhibit Hall Aisle 900
Alzheimer’s tau forms neurofibrillary tangles (NFT), correlated with neuron loss, cognitive decline, & cellular senescence. Exploring senescence transition, cell interactions, & tissue-wide effects requires high-resolution spatial solutions. CosMx SMI reveals spatially correlated gene modules & cell niches. High-plex multiomics, (GeoMx DSP), gives insight into NFT-associated senescence & neurotoxicity. A phospho-tau signature (CellScape) demonstrates rapid scale up model for disease evaluation.